Apoptosis and hepatic necroinflammation

Gastroenterology and Hepatology

Volumn 4, Issue 6, 2008, Pages 394-395

  Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; FAS LIGAND; SORAFENIB; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; CELL FUNCTION; CELL STRESS; CELL SURVIVAL; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER INJURY; NOTE; PROPHYLAXIS; VIRUS HEPATITIS;

EID: 48249153424     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Langer DA, Das A, Semela D, Kang-Decker N, Hendrickson H, et al. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology. 2008 May 5. [Epub ahead of print]
2. Cao L, Du P, Jiang SH, Jin GH, Huang QL, Hua ZC. Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature. Mol Cancer Ther. 2008;7:851-861.
3. Akazawa Y, Gores GJ. Death receptor-mediated liver injury. Semin Liver Dis. 2007;27:327-338.
4. Guicciardi ME, Gores GJ. Cell stress gives a red light to the mitochondrial cell death pathway. Sci Signal. 2008;1:pe9.
5. Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol. 2007;22(Suppl 1):S73-S78.